PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice

Non-alcoholic fatty liver disease (NAFLD) affects 25% of the global adult population, and no effective pharmacological treatment has been found. Products of arachidonic acid metabolism have been developed into a novel therapy for metabolic syndrome and diabetes. It has been demonstrated that protect...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biochem Biophys Res Commun
Autors principals: Sun, Chen-Chen, Zhang, Chen-Yu, Duan, Jia-Xi, Guan, Xin-Xin, Yang, Hui-Hui, Jiang, Hui-Ling, Hammock, Bruce D., Hwang, Sung Hee, Zhou, Yong, Guan, Cha-Xiang, Liu, Shao-Kun, Zhang, Jun
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7990110/
https://ncbi.nlm.nih.gov/pubmed/31973813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2019.12.131
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars